Teresa Domènech
Almirall (Spain)(ES)
Publications by Year
Research Areas
Phosphodiesterase function and regulation, Phenothiazines and Benzothiazines Synthesis and Activities, Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation, Asthma and respiratory diseases
Most-Cited Works
- → Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile(2009)126 cited
- → Characterization of human serotonin 1D and 1B receptors using [ 3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist(1997)75 cited
- → Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants(2002)75 cited
- → Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors(1997)72 cited
- → Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species(1994)71 cited
- → Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)(2009)70 cited
- → Benzyl Derivatives of 2,1,3-Benzo- and Benzothieno[3,2-a]thiadiazine 2,2-Dioxides: First Phosphodiesterase 7 Inhibitors(2000)70 cited
- → Bronchodilator and anti‐inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes(1999)68 cited
- → Phosphodiesterase inhibitory properties of losartan. design and synthesis of new lead compounds(1998)59 cited
- → Characterization of 5‐HT receptors on human pulmonary artery and vein: functional and binding studies(1997)53 cited